blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1881002

EP1881002 - HCV NS-3 serine protease inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.08.2009
Database last updated on 07.10.2024
Most recent event   Tooltip14.08.2009Application deemed to be withdrawnpublished on 16.09.2009  [2009/38]
Applicant(s)For all designated states
Tibotec Pharmaceuticals Ltd.
Eastgate Village Eastgate Little Island
Co Cork / IE
For all designated states
MEDIVIR AB
Lunastigen 7
141 44 Huddinge / SE
[2008/04]
Inventor(s)01 / Salvador Oden, Lourdes
c/o Medivir AB Lunastigen 7
S-141 44, Huddinge / SE
02 / Nilsson, Karl Magnus
c/o Medivir AB Lunastigen 7
S-141 44, Huddinge / SE
03 / Rosenquist, Asa Annica Kristina
c/o Medivir AB Lunastigen 7
S-141 44, Huddinge / SE
04 / Samuelsson, Bengt Bertil
c/o Medivir AB Lunastigen 7
S-141 44, Huddinge / SE
05 / Raboisson, Pierre Jean-Marie Bernard
Rue Jolie 3
1331, Rosieres / BE
06 / De Kock, Herman
Wolfseind 10
2370, Arendonk / BE
07 / Vendeville, Sandrine Marie Helene
Rue du Bémel 142
1150, Woluwe-Saint-Pierre / BE
08 / Simmen, Kenneth Alan
Boterbloemenlaan 35
3080, Tervuren / BE
 [2008/04]
Representative(s)Wante, Dirk Paul Maria, et al
Tibotec-Virco Virology BVBA Generaal De Wittelaan L11 B3
2800 Mechelen / BE
[N/P]
Former [2009/29]Wante, Dirk Paul Maria, et al
Tibotec-Virco Comm. VA J&J Patent Law Department Generaal De Wittelaan L11 B3
2800 Mechelen / BE
Former [2008/04]Wante, Dirk Paul Maria, et al
Tibotec-Virco Comm. VA J&J Patent law department Generaal De Wittelaan L 11B 3
B-2800 Mechelen / BE
Application number, filing date07112899.520.07.2007
[2008/04]
Priority number, dateEP2006011760520.07.2006         Original published format: EP 06117605
[2008/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1881002
Date:23.01.2008
Language:EN
[2008/04]
Search report(s)(Supplementary) European search report - dispatched on:EP28.11.2007
ClassificationIPC:C07K5/02, C07D215/00, A61K38/55, A61K38/05, A61K38/06, A61K38/07
[2008/04]
CPC:
C07K5/0217 (EP); C07K5/02 (EP); A61K38/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/04]
TitleGerman:HCV-NS-3-Serinproteaseinhibitoren[2008/04]
English:HCV NS-3 serine protease inhibitors[2008/04]
French:Inhibiteurs de la sérine protéase HCV NS-3[2008/04]
Examination procedure23.07.2008Examination requested  [2008/36]
08.10.2008Despatch of a communication from the examining division (Time limit: M04)
19.02.2009Application deemed to be withdrawn, date of legal effect  [2009/38]
01.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/38]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO2005010029  (ENANTA PHARM INC [US], et al) [X] 1-3,8-10 * page 4, line 27 - page 5, line 1; examples 4-24 * * Formula I * [Y] 4-7;
 [Y]WO2005073195  (MEDIVIR AB [SE], et al) [Y] 4-7 * Formula VI, Examples 39, 40 *;
 [A]WO2005113581  (SCHERING CORP [US], et al) [A] 1-10* claim 24 *;
 [A]  - KAI LIN, ANN D KWONG, CHAO LIN, "Combination of a Hepititis C Virus NS3-NS4A Protease Inhibitor and Alpha Interferon Synergistically Inhibits Viral RNA Replication and Facilitates Viral RNA Clearance in Replicon Cells", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (200412), vol. 48, no. 12, pages 4784 - 4792, XP002447085 [A] 1-10 * figure 1 *

DOI:   http://dx.doi.org/10.1128/AAC.48.12.4784-4792.2004
 [A]  - PERNI R B ET AL, "INHIBITORS OF HEPATITIS C VIRUS NS3.4A PROTEASE. PART 3: P2 PROLINE VARIANTS", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20040419), vol. 14, no. 8, ISSN 0960-894X, pages 1939 - 1942, XP008037248 [A] 1-10 * compound 3 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2004.01.078
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.